Israel Englander Absci Corp Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Absci Corp stock. As of the latest transaction made, Millennium Management LLC holds 229,959 shares of ABSI stock, worth $682,978. This represents 0.0% of its overall portfolio holdings.

Number of Shares

229,959

Previous 1,075,126 78.61%

Holding current value

$682,978

Previous $2.7 Million 78.13%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$2.24 - $3.22 $1.89 Million - $2.72 Million	-845,167 Reduced 78.61%	229,959 $590,000
Q1 2025 May 15, 2025	BUY	$2.51 - $5.82 $2.64 Million - $6.11 Million	1,049,900 Added 4161.98%	1,075,126 $2.7 Million
Q4 2024 Feb 14, 2025	SELL	$2.55 - $4.38 $2.93 Million - $5.04 Million	-1,149,603 Reduced 97.85%	25,226 $66,000
Q3 2024 Nov 14, 2024	BUY	$2.97 - $4.49 $1.08 Million - $1.63 Million	363,056 Added 44.72%	1,174,829 $4.49 Million
Q2 2024 Aug 14, 2024	SELL	$2.92 - $6.58 $2.8 Million - $6.31 Million	-958,221 Reduced 54.14%	811,773 $2.5 Million
Q1 2024 May 15, 2024	BUY	$3.41 - $5.74 $4.24 Million - $7.13 Million	1,242,254 Added 235.39%	1,769,994 $10.1 Million
Q4 2023 Feb 14, 2024	SELL	$1.15 - $4.79 $272,225 - $1.13 Million	-236,718 Reduced 30.97%	527,740 $2.22 Million
Q2 2023 Aug 14, 2023	BUY	$1.17 - $2.03 $478,829 - $830,789	409,256 Added 115.22%	764,458 $1.16 Million
Q1 2023 May 15, 2023	SELL	$1.58 - $3.41 $243,925 - $526,446	-154,383 Reduced 30.3%	355,202 $622,000
Q4 2022 Feb 14, 2023	BUY	$2.0 - $3.58 $281,866 - $504,540	140,933 Added 38.23%	509,585 $1.07 Million
Q3 2022 Nov 14, 2022	BUY	$2.95 - $4.83 $1.02 Million - $1.67 Million	345,130 Added 1467.26%	368,652 $1.15 Million

Others Institutions Holding ABSI

# of Institutions

140

Shares Held

68.6M

Call Options Held

469K

Put Options Held

543K

View Full List

About Absci Corp

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $276M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

More about ABSI

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account